INIS
patients
100%
drugs
86%
rats
53%
diseases
52%
evaluation
44%
comparative evaluations
43%
control
42%
hospitals
37%
doses
37%
levels
28%
india
28%
hiv
25%
data
24%
males
24%
risks
24%
therapy
20%
assessments
18%
females
18%
cancer
17%
reviews
16%
learning
16%
mice
16%
mortality
16%
pharmacology
15%
death
14%
humans
14%
safety
13%
animals
13%
blood
12%
populations
12%
management
11%
values
11%
teaching
11%
sex
11%
fruits
10%
adults
9%
antidepressants
9%
diabetes mellitus
9%
inflammation
9%
liver
9%
nervous system diseases
9%
correlations
8%
viruses
8%
hypertension
8%
administration
8%
tuberculosis
8%
clinical trials
8%
glucose
8%
toxicity
7%
attitudes
7%
kidneys
7%
cholesterol
7%
weight
7%
people
7%
diuretics
7%
damage
7%
symptoms
7%
antioxidants
7%
education
6%
lipids
6%
pediatrics
6%
oxidation
6%
interventions
6%
fasting
6%
injuries
6%
children
6%
reduction
6%
food and drug administration
6%
creatinine
6%
usa
6%
malaria
6%
ulcers
5%
interactions
5%
vaccines
5%
units
5%
insulin
5%
performance
5%
exercise
5%
urea
5%
tools
5%
antibiotics
5%
proteins
5%
blood pressure
5%
information
5%
diet
5%
cardiovascular diseases
5%
quality of life
5%
laboratories
5%
analgesics
5%
lipoproteins
5%
Pharmacology, Toxicology and Pharmaceutical Science
Wistar Rat
27%
Adverse Event
25%
HIV
25%
Disease
19%
Diabetes Mellitus
15%
Global Disease Burden
13%
Prevalence
10%
Adverse Drug Reaction
8%
Cross-Sectional Study
7%
Antidepressant Activity
7%
Prospective Study
7%
Vanillin
7%
Diuretic Activity
7%
Gentamicin
6%
Antidiabetic Agent
6%
Albino Mouse
6%
Alzheimer's Disease
6%
Malignant Neoplasm
6%
Resveratrol
5%
Clinical Trial
5%
Human Immunodeficiency Virus Infection
5%
Creatinine
5%
Analgesic Agent
5%
Metformin
5%
Hepatotoxicity
5%
Polypharmacy
5%
Medicine and Dentistry
Global Disease Burden
26%
Disability Adjusted Life Years
11%
Disease
10%
Human Immunodeficiency Virus
9%
Malignant Neoplasm
7%
Tertiary Care
7%
Prevalence
6%
Diabetes
6%
Adverse Event
6%
Diabetes Mellitus
5%
Maturity Onset Diabetes of the Young
5%